Pallas Health vs Oak Longevity: Compounded GLP-1 Prices and Care
Quick verdict: For patients prioritizing clinician choice between brand-name pens and compounded preparations, Pallas Health offers clinician-personalized plans and provider care included; for cost-conscious buyers seeking the lowest flat monthly price and no subscription, Oak Longevity starts lower on semaglutide pricing.
See Pallas Health plans and clinician options
Pallas Health vs Oak Longevity: what the comparison is based on
This comparison of Pallas Health vs Oak Longevity focuses on distinct, evidence-backed differences: pricing structure and starting prices; availability of brand-name versus only compounded products; clinician and care inclusions; subscription and billing model; and shipping and fulfillment features. All statements below reflect the supplied source material and preserve qualifiers such as starting at, from, and subject to clinician review.
Price and billing: starting prices and how you pay
Pallas Health advertises compounded semaglutide at $139 for the first month, then $597 every 12 weeks, a $199/month average. Compounded tirzepatide is $179 first month, then $897 every 12 weeks, a $299/month average. Brand-name Wegovy, Ozempic, Zepbound and Mounjaro are listed as cash-pay monthly figures on the Pallas page.
Oak Longevity lists semaglutide from $133/month and tirzepatide from $199/month and emphasizes one flat price that covers all dosages. Oak bills monthly on a non-recurring basis with no subscription, and three-month prescriptions are billed upfront for some options.
View Oak Longevity pricing and monthly billing
Product types and clinician selection
Pallas Health offers both FDA-approved brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro) and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Oak Longevity offers compounded semaglutide and compounded tirzepatide only, described as compounded versions of the active ingredients in the brand drugs.
Care model, review process, and extras
Pallas includes provider care, clinician review, ongoing check-ins and care-team messaging inside a single plan price with no membership fee. The Pallas intake may be asynchronous in most states but requires a video visit in seven states plus Washington, D.C. Pallas notes eligibility is determined by a US-licensed clinician and that care-team hours are weekdays 9 AM to 5 PM ET.
Oak Longevity states board-certified physicians in your state review every case, the clinical review is asynchronous with no video call required, and free health coaching is included. Oak emphasizes no subscriptions, no membership fees, free shipping with tracking, and same-day approval for qualifying patients.
Compare Pallas clinician-led care and check-ins
Regulatory and shipping notes
Both providers offer compounded medications and explicitly state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Pallas notes compounded medications are prepared by US-licensed compounding pharmacies and that the medication you receive may differ in appearance from site images. Both providers advertise free shipping; Pallas specifies free expedited and discreet shipping, Oak specifies free shipping with tracking.
Quick comparison table
| Criteria | Pallas Health | Oak Longevity |
|---|---|---|
| Starting price semaglutide | $139 first month; $199/mo avg | $133/month |
| Starting price tirzepatide | $179 first month; $299/mo avg | $199/month |
| Brand-name options | Offers Wegovy, Ozempic, Zepbound, Mounjaro | Compounded only |
| Billing model | Compounded plans renew every 12 weeks; brand-name cash-pay monthly | Monthly non-recurring billing; no subscription; three-month upfront for some |
| Care included | Provider care, check-ins, messaging included in plan | Free health coaching; physician review included |
| Video visit requirement | Required in seven states plus D.C.; asynchronous in most states | No video call required |
| Shipping | Free expedited, discreet shipping | Free shipping with tracking; same-day approval for qualifying patients |
Who each provider is best for
Pallas Health is best for patients who want a clinician to choose between brand-name pen medications and a per-patient compounded preparation, with provider care and messaging included in the plan price. Pallas also suits people who prefer a structured renewal cadence and explicit clinician oversight, remembering that compounded medications are not FDA-approved and that Pallas is cash-pay only.
Start Pallas intake to see clinician options
Oak Longevity is best for cost-conscious patients with an uncomplicated health history who want one flat price for all dosages, no subscription, and free health coaching. Oak emphasizes lower starting monthly prices for compounded semaglutide and tirzepatide and an entirely asynchronous intake with no video call for most patients.
Check Oak Longevity availability and pricing
Conclusion
In a Pallas Health vs Oak Longevity comparison, choose Pallas if you want clinician-led choice between FDA-approved pens and compounded options with provider care included. Choose Oak Longevity if you prioritize the lowest flat monthly price for compounded semaglutide or tirzepatide and want no subscription with free coaching and shipping. Both providers note that compounded medications are not FDA-approved and eligibility is determined by a licensed clinician.